Effect of Enhanced Recovery After Surgery for Benign Anorectal Conditions

NCT ID: NCT06803550

Last Updated: 2025-02-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-12-17

Study Completion Date

2025-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to assess the role of Enhanced recovery after surgery(ERAS) protocol in reducing postoperative urine retention (POUR) after surgery for benign anorectal conditions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study aims to assess the role of Enhanced recovery after surgery(ERAS) protocol in reducing postoperative urine retention (POUR) after surgery for benign anorectal conditions.

Patients of both sexes aged between 18 and 90 years old presented; with benign anorectal conditions including chronic anal fissure, hemorrhoids, and fistula-in-ano will be eligible for the study.

Eligible patients will be randomized in equal proportions to RRAS or ROUTINE pathways. The ERAS pathway was developed based on the available guidelines and protocols it includes 14 items.

Patients allocated to ERAS pathway must fulfill all the 14 items. The ROUTINE pathway will represent the routine practice which may include certain ERAS items or those who will not fulfill the 14 items.

For the end points of the study, all patients will be followed-up by a phone call 72 hours postoperatively then in the outpatients' department for a period of a total of 30 days postoperatively. However, patients will be advised to visit the outpatients' department at any other time during the trial if they developed any unfavorable event.

The primary outcome will be the 72-hours postoperative urinary retention after anorectal surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anal Fistula Anal Fissure Chronic Haemorrhoid Enhanced Recovery After Surgery (ERAS) Protocol

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Enhanced recovery after surgery protocol

ERAS pathway was developed based on the available guidelines and protocols it includes 14 items

Group Type ACTIVE_COMPARATOR

Enhanced recovery after surgery protocol

Intervention Type OTHER

ERAS pathway was developed based on the available guidelines and protocols it includes 14 items:

1. Preoperative patient education using an information sheet which includes instructions on postoperative wound care, pain management, and preventing and managing constipation.
2. Single preoperative enema 2 hours prior to surgery.
3. Solid or semisolid food stopped 6 hours before surgery.
4. Clear liquids may be continued up to 2 hours before surgery.
5. Preoperative carbohydrate loading in non-diabetic patients for up to 2 hours prior to surgery in the form of a single 330 ml high-carbohydrate clear drink (apple juice).
6. Saddle anesthesia.
7. Single dose of intravenous 500 mg metronidazole at the time of the anaesthesi induction.
8. Restriction of intraoperative intravenous fluids to less than 500 ml.
9. Balanced chloride-restricted crystalloid solutions should be used for maintenance infusions and fluid boluses.
10. A bundle measures to reduce surgical site infection which includes

Routine practice

This is the routine preoperative preparation

Group Type OTHER

Routine pathway

Intervention Type OTHER

This is the routine preoperative preparation at our institute

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Enhanced recovery after surgery protocol

ERAS pathway was developed based on the available guidelines and protocols it includes 14 items:

1. Preoperative patient education using an information sheet which includes instructions on postoperative wound care, pain management, and preventing and managing constipation.
2. Single preoperative enema 2 hours prior to surgery.
3. Solid or semisolid food stopped 6 hours before surgery.
4. Clear liquids may be continued up to 2 hours before surgery.
5. Preoperative carbohydrate loading in non-diabetic patients for up to 2 hours prior to surgery in the form of a single 330 ml high-carbohydrate clear drink (apple juice).
6. Saddle anesthesia.
7. Single dose of intravenous 500 mg metronidazole at the time of the anaesthesi induction.
8. Restriction of intraoperative intravenous fluids to less than 500 ml.
9. Balanced chloride-restricted crystalloid solutions should be used for maintenance infusions and fluid boluses.
10. A bundle measures to reduce surgical site infection which includes

Intervention Type OTHER

Routine pathway

This is the routine preoperative preparation at our institute

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* both sexes
* aged between 18 and 65 years old
* presented with benign anorectal conditions including chronic anal fissure, hemorrhoids, and fistula-in-ano will be eligible for the study

Exclusion Criteria

* younger than 18
* older than 65 years old
* pregnant female
* history of relevant urological diagnosis (benign prostatic hyperplasia/prostate cancer/urethral stricture/bladder neck stenosis/detrusor underactivity/detrusor overactivity)
* history of relevant urological procedure (radical prostatectomy/ transurethral prostatectomy/bladder neck or urethral surgery/pelvic radiotherapy)
* use of permanent urinary catheter
* intraoperative urological procedures
* with any form of urinary diversion
* severe cognitive impairment
* who undergo other anorectal procedures
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mansoura University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mostafa shalaby, MD, MSc, PhD

Associate Professor & Consultant Colorectal Surgery

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mostafa Shalaby, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Mansoura University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mansoura University Hospital

Al Mansurah, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mostafa Shalaby, MD, PhD

Role: CONTACT

00201020555605

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mostafa Shalaby, MBBCh, MSc, MD, PhD, FACS

Role: primary

00201020555605

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R.24.11.2877

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Platelet- Rich Plasma Injection
NCT06887166 COMPLETED NA
Bowel Preparation Before Hemorrhoidectomy
NCT06403774 ENROLLING_BY_INVITATION NA